Millennium Management »

Bridgebio Oncology Therapeut shares owned by Millennium Management

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.1M 370k 10.98

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut